UNH UnitedHealth Group Incorporated Common Stock (DE)

NYSE · Health Care · ดูใน SEC EDGAR ↗
$397.54
ราคา · ส.ค. 18, 2026
ข้อมูลพื้นฐาน ณ วันที่ ส.ค. 10, 2026

เกี่ยวกับ UnitedHealth Group Incorporated Common Stock (DE) ภาพรวมบริษัทจาก Wikipedia

UnitedHealth Group Incorporated is an American multinational for-profit company based in Eden Prairie, Minnesota, specializing in health insurance and health care services. Selling insurance products under UnitedHealthcare, and health care services under the Optum brand, it is the world's fourth-largest company by revenue and the largest health care company by revenue. The company is ranked fourth on the 2026 Fortune Global 500.

อ่านเพิ่มเติม

UnitedHealth Group Incorporated is an American multinational for-profit company based in Eden Prairie, Minnesota, specializing in health insurance and health care services. Selling insurance products under UnitedHealthcare, and health care services under the Optum brand, it is the world's fourth-largest company by revenue and the largest health care company by revenue. The company is ranked fourth on the 2026 Fortune Global 500.

UnitedHealth Group had a market capitalization of more than $400 billion as of year-end 2025. The company is the largest health insurer in the United States, insuring over 50 million people, and operates globally.

UnitedHealth Group has faced numerous investigations, lawsuits, and fines, including SEC enforcement for stock option backdating, Medicare over-billing, unfair claims practices, mental health treatment denials, and anticompetitive behavior.

History

1970s–1990s

UnitedHealth Group originated in late 1974, when Minnesota-based Charter Med Incorporated was founded by Richard Taylor Burke. It originally processed claims for doctors at the Hennepin County Medical Society. UnitedHealthcare Corporation was founded in 1977 to purchase Charter Med and create a network-based health plan for seniors. It became a publicly traded company in 1984 and changed its name to UnitedHealth Group in 1998.

In 1988, UnitedHealthcare started its first pharmacy benefit management, through its Diversified Pharmaceutical Services subsidiary. It managed pharmacy benefits delivered both through retail pharmacies and mail. The subsidiary was sold to SmithKline Beecham in 1994 for $2.3 billion.

In 1994, UnitedHealthcare acquired Ramsey-HMO, a Florida insurer. In 1995, the company acquired The MetraHealth Companies Inc. for $1.65 billion. MetraHealth was a privately held company formed by combining the group healthcare operations of The Travelers Companies and MetLife. In 1996, UnitedHealthcare acquired HealthWise of America, which operated HMOs in Arkansas, Maryland, Kentucky and Tennessee.

In 1998, the company was reorganized as the holding company for hitherto independent companies UnitedHealthcare, Ovations, Uniprise, Specialized Care Services, and Ingenix and rebranded as "UnitedHealth Group". Also in 1998, UnitedHealth Group acquired HealthPartners of Arizona, operator of Arizona's largest AHCCCS provider.

2000s

In 2001, EverCare, a UnitedHealth Group subsidiary, merged with LifeMark Health Plans In 2002, UnitedHealth Group acquired GeoAccess and Medicaid insurance company AmeriChoice. In 2003, UnitedHealth Group acquired Mid Atlantic Medical Services, an insurer serving Maryland, Washington D.C., Virginia, Delaware and West Virginia. Also in 2003, UnitedHealth Group acquired Golden Rule Financial, a provider of health savings accounts. On July 21, 2003, Exante Bank started operating in Salt Lake City, Utah, as a Utah state-chartered industrial loan corporation. It changed its name to OptumHealth Bank in 2008 and to Optum Bank in 2012.

In April 2004, UnitedHealth Group acquired Touchpoint Health Plan, a Wisconsin health plan. In July 2004, the company acquired Oxford Health Plans.

In December 2005, the company acquired PacifiCare Health Systems. It agreed to divest parts of PacifiCare's commercial health insurance business in Tucson, Arizona and Boulder, Colorado to satisfy antitrust regulator concerns, and also agreed to end its network access agreement with Blue Shield of California. The Tucson business was sold to Cigna. The company acquired Prescription Solutions, another pharmacy benefits manager, as part of its acquisition of PacifiCare Health Systems. This business was later rebranded OptumRx.

In February 2006, the company acquired John Deere Health Care. The same year, William W. McGuire stepped down as chairman and director due to his involvement in the employee stock options scandal. He was replaced by CEO Stephen Hemsley who had served as president and COO and a member of the board of directors. McGuire's exit compensation from UnitedHealth was anticipated to be $1.1 billion, but he only received $618 million after returning $420 million in stock options.

In February 2008, the company acquired Sierra Health Services for $2.6 billion. As part of the transaction, to obtain regulatory approval, 25,000 customers were sold to Humana. In July 2009, UnitedHealth Group agreed to acquire Health Net's Northeast licensed subsidiaries for up to $570 million in payments spread out over two years.

2010s

Through 2010 and into 2011, senior executives of the company met monthly with executives of other health insurers to limit the effect of the health care reform law. In July 2010, Ingenix acquired Picis Clinical Solutions, Inc., a health information provider for the high-acuity areas of hospitals. In 2011, Logistics Health, Inc. of La Crosse, Wisconsin, was acquired by OptumHealth. In September 2014, the office buildings where LHI is based were sold to UnitedHealth Group for $45 million. In February 2012, the company acquired XLHealth, a sponsor of Medicare Advantage health plans with a primary focus on medicare recipients with special needs such as those with chronic illness and those eligible for Medicaid ("dual eligibles"). In October 2012, UnitedHealth Group and Amil Participações, one of the biggest Brazilian health insurance companies, completed the first phase of their merger.

In February 2014, Optum secured a majority stake in the Washington, D.C.–based startup Audax Health. Audax's CEO, Grant Verstandig, continued running the firm alongside COO David Ko. In October 2014, Optum Health acquired the health services unit of Alere for $600 million cash.

In March 2015, it was announced that CatamaranRx would be acquired by OptumRx. In April 2016, the company announced it was pulling out of all but a "handful" of state healthcare exchanges provided under Affordable Care Act and will continue to sell only in three states in 2017.

In 2017, UnitedHealth's Optum unit acquired Rally Health, a company started by Audax Health's executives. Prior to acquisition, in 2015, UnitedHealth supported Rally Health as a majority investor, and through enrolling more than 5 million UnitedHealth policy holders in Rally Health's flagship product, Rally. The close relations between UnitedHealth, Audax Health and Rally Health follows a close personal relationship between Grant Verstandig (Audax and Rally) and UnitedHealth's President and CFO at the time, David Wichmann.

In June 2019, UnitedHealth's Optum division acquired DaVita Medical Group from DaVita, Inc. for $4.3 billion. That year, the company also agreed to acquire Equian for $3.2 billion. On June 19, 2019, UnitedHealth acquired the online patient community platform PatientsLikeMe for an undisclosed amount and it will be incorporated into UnitedHealth Group's research division.

In November 2019, Andrew Witty was named president of UnitedHealth Group, in addition to his role as chief executive of the company's Optum division.

2020s–present

UnitedHealth announced in March 2022 that it would acquire LHC Group for $5.4 billion. The deal will expand its home health capabilities by combining LHC's services with UnitedHealth's Optum unit.

In 2022, UnitedHealth Group said there would be no out-of-pocket costs for albuterol, epinephrine, glucagon, insulin, and naloxone for fully insured members starting in 2023. The discounts were guaranteed for less than a quarter of UnitedHealthcare's membership and did not extend to those enrolled in UHC's Medicare Advantage and Medicaid plans.

In 2023, UnitedHealthGroup announced it would move its headquarters from Minnetonka to Eden Prairie, Minnesota.

In February 2024, UnitedHealth Group completed the sale of its operations in Brazil.

In January 2021, UnitedHealth announced the acquisition of Change Healthcare, the largest health payments platform in the US, which the US Justice Department tried to block on antitrust grounds in February 2022; the sale went through by September. 18 months later, in February 2024, the subsidiary was brought completely down by the 2024 Change Healthcare ransomware attack, and the Justice Department announced that it was opening a new antitrust and Medicare overcharging probe. Despite making a ransomware payment, services remained down or incomplete for months. The CEO, Andrew Witty, was called before the US House and US Senate to testify about the cyberattack and DoJ concerns. In late April 2024, the Senate held a hearing concerning the cyberattack and UnitedHealth's response. Andrew Witty went before the Senate stating that there needed to be a strong digital security system in place along with an adequate backup plan. UnitedHealth revealed the hackers did gain access to patient information, but the Senate was informed the company is not yet aware of the extent of the data breach.

In June 2026, UnitedHealth Group announced plans to invest $3 billion in artificial intelligence in 2026 and 2027.

Killing of Brian Thompson

On December 4, 2024, Brian Thompson, the CEO of UnitedHealth Group's insurance subsidiary UnitedHealthcare, was killed in a shooting in New York City. The shooting occurred outside the New York Hilton Midtown, where UnitedHealth Group was hosting an investor event. Reactions to the shooting on social media were defined by resentment and criticism of UnitedHealthcare, the American health insurance system, and widespread disdain towards Thompson. Police later arrested a suspect, Luigi Mangione, and charged him with murder. Tim Noel joined UnitedHealthcare in 2007 and succeeded Brian Thompson as the CEO. Prior to becoming CEO, Noel was in charge of UnitedHealthcare's Medicare Advantage plans.

Further events

In November 2025, Scott Gottlieb, the former commissioner of the Food and Drug Administration, joined UnitedHealth Group's board of directors.

Organizational structure

UnitedHealth Group has about 2700 subsidiaries and affiliates worldwide, the highest profile being Optum and UnitedHealthcare.

Optum

Formed in 2011, Optum says that it provides "data and analytics, pharmacy care services, population health, healthcare delivery, and healthcare operations".

It is organized into three businesses:

OptumHealth – provides primary and secondary care.

OptumInsight – provides data analytics, technology, and operations services.

OptumRX – provides pharmacy services.

UnitedHealthcare

UnitedHealthcare (UHC) is an insurance and managed care company with three main divisions:

UnitedHealthcare Employer and Individual – provides health benefit plans and services for large national employers and individuals.

UnitedHealthcare Medicare and Retirement – provides health and well-being services to individuals age 65 and older.

UnitedHealthcare Community and State – serves state programs that care for the economically disadvantaged, the medically underserved, and people without the benefit of employer-funded health care coverage, in exchange for a monthly premium per member from the state program.

Finance

For the fiscal year 2022, UnitedHealth Group reported earnings of US$20.64 billion, with an annual revenue of US$324.16 billion. UnitedHealth Group's 2023 revenue grew by $47.5 billion, or 14.6%, on annualized revenue of $371.6 billion. Operating income for 2023 was $32.4 billion (up 13.8%). Cash flows from operations were $29.1 billion. UnitedHealth Group’s 2024 revenues grew $28.7 billion or 8% year-over-year to $400.3 billion. Earnings from operations of $32.3 billion compared to $32.4 billion in 2023. Cash flows from operations were $24.2 billion.

Lobbying and political activity

In 2009, according to OpenSecrets, people affiliated with UnitedHealth Group gave $4.77 million to political candidates and groups. The Affordable Care Act was being discussed in Congress at the time and was subsequently passed in the first quarter of 2010. In 2010 UnitedHealth Group hired nine different lobbying firms to work on its behalf. In addition, its corporate political action committee (PAC), called United for Health, spent an additional $1 million on lobbying activities. UnitedHealth Group subsequently spent $4.11 million to $4.75 million from 2011 to 2021.

The Lewin Group

The Lewin Group is a policy research and consulting firm that provides an economic analysis of health care and human services issues and policies. The organization has existed for about 40 years and has maintained a nonpartisan reputation through the many ownership changes that have occurred over that time. The Lewin Group was purchased in 2007 by Ingenix, a subsidiary of UnitedHealth Group, but alleges editorial and analytical "independence" from UnitedHealth Group, its parent company. The Lewin Group discloses its ownership in its reports and on its website. While the Lewin Group does not advocate for or against any legislation, both Democratic and Republican politicians frequently cite the firm's studies to argue for and against various U.S. healthcare reform proposals. For example, Democratic Senator Ron Wyden uses Lewin Group estimates to cite the feasibility of his Healthy Americans Act. Former U.S. Representative Eric Cantor, the former House Republican Whip, has referred to the organization as "the nonpartisan Lewin Group" in arguing against government-funded health insurance proposals.

Several Lewin studies have been used to argue both for and against the inclusion of a public option in national health reform. Lewin clients who often cite its findings include The Commonwealth Fund, which, in 2009, held up a Lewin study it commissioned to advocate for a public plan. The report showed that legislative proposals would achieve nearly universal coverage and "estimated that a public plan could offer small businesses insurance that is at least 9 percent cheaper than current small-business policies."

However, the Lewin Group has acknowledged that clients sometimes choose to keep the results of studies they have commissioned private. Indeed, Lewin Group Vice President John Sheils told The Washington Post that "sometimes studies come out that don't show exactly what the client wants to see. And in those instances, they have [the] option to bury the study."

Criticism and controversies

SEC investigation

In 2006, the U.S. Securities and Exchange Commission (SEC) began investigating the conduct of UnitedHealth Group's management and directors, for backdating of stock options. Investigations were also started by the Internal Revenue Service and prosecutors in the U.S. attorney's office for the Southern District of New York, who subpoenaed documents from the company. The investigations came to light after a series of probing stories in the Wall Street Journal in May 2006, discussing the apparent backdating of hundreds of millions of dollars' worth of stock options by UHC management. The backdating apparently occurred with the knowledge and approval of the directors, according to the Journal. Major shareholders have filed lawsuits accusing former New Jersey governor Thomas Kean and UHC's other directors of failing in their fiduciary duty. On October 15, 2006, CEO William W. McGuire was forced to resign, and relinquish hundreds of millions of dollars in stock options.

On December 6, 2007, the SEC announced a settlement under which McGuire was to repay $468 million, including a $7 million civil penalty, as a partial settlement of the backdating prosecution. He was also barred from serving as an officer or director of a public company for ten years. This was the first time in which the little-used "clawback" provision under the Sarbanes-Oxley Act was used against an individual by the SEC. The SEC continued its investigations even after it in 2008 settled legal actions against both UnitedHealth Group itself and its former general counsel.

American Chiropractic Association lawsuit

In June 2006, the American Chiropractic Association filed a national class-action lawsuit against the American Chiropractic Network (ACN), which is owned by UnitedHealth Group and administers chiropractic benefits, and against UnitedHealth Group itself, for alleged practices in violation of the federal Racketeer Influenced and Corrupt Organizations Act (RICO). The Missouri Department of Insurance, Financial Institutions and Professional Registration determined that UnitedHealth Group violated state insurance laws, so levied $536,000 in fines and ordered more than 50,000 cases re-opened; any improperly denied claims must have been reimbursed with interest for chiropractors and patients.

OptumInsight, a.k.a. Ingenix lawsuit

In February 2008, New York State Attorney General Andrew Cuomo announced an industry-wide investigation into a scheme by health insurers to defraud consumers by manipulating reasonable and customary rates. The announcement included a statement that Cuomo intended "to file suit against Ingenix, Inc., its parent UnitedHealth Group, and three additional subsidiaries." Cuomo asserted that his investigation found that rates found in a database of health care charges maintained by Ingenix were lower than what he determined was the actual cost of certain medical expenses. Cuomo said this inappropriately allowed health insurance companies to deny a portion of provider claims, thereby pushing costs down to members.

On January 13, 2009, Ingenix announced an agreement with the New York State attorney settling the probe into the independence of the health pricing database. Under the settlement, UnitedHealth Group and Ingenix would pay $50 million to finance a new, non-profit entity that would develop a new healthcare pricing database. Ingenix would discontinue its medical pricing databases when the new entity makes its product available. The company acknowledged the appearance of a conflict of interest but admitted no wrongdoing.

On January 15, 2009, UnitedHealth Group announced a $350 million settlement of three class action lawsuits filed in Federal court by the American Medical Association, UnitedHealth Group members, healthcare providers, and state medical societies for not paying out-of-network benefits. This settlement came two days after a similar settlement with Cuomo.

On October 27, 2009, Cuomo announced the creation of FAIR Health, an independent, non-profit organization that would develop a nationwide database for consumer reimbursement, as well as a website where consumers would be able to compare prices before choosing doctors. To fund FAIR Health, the Attorney General's office secured nearly $100 million from insurers such as Aetna, UnitedHealth Group, and Anthem Inc.

PacifiCare fine in California

In 2008, the California Department of Insurance took action against UnitedHealthcare's subsidiary PacifiCare Health Systems, acquired in 2005, ultimately fining UnitedHealthcare around $173 million for an estimated over 900,000 violations of the Unfair Insurance Practices Act; by 2019, the case was still being disputed in court, with the possibility of affirming $91 million in penalties.

Medicare overbilling lawsuit

A whistleblower lawsuit filed in 2011 charged UnitedHealth Group's data analytics division with assisting in defrauding Medicare by boosting risk adjustment scores from Medicare Advantage companies. The suit alleged that UnitedHealth Group subsidiary Ingenix (now OptumInsight) "defrauded the United States of hundreds of millions – and likely billions – of dollars." Former UnitedHealth executive Benjamin Poehling brought the suit under the False Claims Act. The government said it would proceed on claims against two healthcare companies, UnitedHealth and its Texas subsidiary WellMed Medical Management. In February 2017, a federal judge unsealed the suit after the Department of Justice announced it would join the case.

CMS fine over Medicare Part D

In 2017, the Centers for Medicare and Medicaid Services (CMS) fined UnitedHealthcare $2.5 million after discovering issues in Medicare Part D leading to delays or denials in a 2016 audit.

2018 New Jersey fine

In 2018, the New Jersey Department of Banking and Insurance fined UnitedHealthcare $2.5 million due to various compliance issues; this was the largest fine against a licensee in nine years.

Richard Cole, and others v. UnitedHealthcare

On April 29, 2019, Judge Robert N. Scola Jr. of the United States District Court for the Southern District of Florida, a cancer survivor, recused himself from a case against UnitedHealthcare, stating that the company's denial of treatment was "immoral and barbaric", and that his opinions regarding the company would prevent him from "deciding this case fairly and impartially."

Mental health treatment lawsuit

As reported by openminds.com:

On September 13, 2019, three addiction and mental health treatment centers sued United Behavioral Health (UBH), UnitedHealthcare's mental health subsidiary. The centers alleged that UBH wrongfully denied $5 million in behavioral health treatment claims for self-insured and fully insured employer health plans for residential and outpatient treatment from 2011 to 2017. The case involves claims for 157 employer group health plan members, including children.

Pennsylvania lawsuit

In 2019, UnitedHealthcare paid a $1 million penalty to settle Pennsylvania regulators' allegations that the company violated state and federal laws when paying medical claims, particularly for patients seeking treatment for autism and substance use disorders. The regulators also compelled the company to pay restitution for wrongly denied or delayed claims and to spend $800,000 on an outreach campaign to notify consumers of their mental health and substance use disorder benefits.

Dispute with TeamHealth

In late 2021, Tennessee-based physician network TeamHealth, a subsidiary of the private equity company Blackstone Inc., sued UnitedHealthcare in the 8th District Court of Clark County, Nevada, alleging the insurer underpaid claims to three of TeamHealth's Nevada-based affiliates. In November 2021, the jury unanimously found United guilty of "oppression, fraud, and malice" in its conduct and awarded TeamHealth $2.65 million in compensatory damages. In December, the jury reconvened to determine punitive damages and awarded TeamHealth $60 million. TeamHealth plans to pursue similar legal action against United and other insurers in New Jersey, Pennsylvania, New York, Florida, Oklahoma, and Texas.

Medicare Advantage overbilling

An October 2021 New York Times report identified UnitedHealth in a list of Medicare insurers accused of over-billing. According to the Inspector General, a whistleblower came forward, so the U.S. government went after UnitedHealth for over-billing Medicare. Executives at UnitedHealth Group told workers to mine old medical records for more illnesses, to identify diagnoses of serious diseases that might have never existed, inflating bills paid by the federal government's Medicare Advantage program.

A study by the Kaiser Family Foundation found that in 2021, Medicare Advantage programs provided insurers with double the gross margin of insurance for individuals, groups, or Medicaid Managed Care.

In July 2024, the Wall Street Journal concluded that UnitedHealth was the worst offender among private insurers who made dubious diagnoses in their clients in order to trigger large payments from the government's Medicare Advantage program. The patients often did not receive any treatment for those insurer-added diagnoses. The report, based on Medicare data obtained from the federal government under a research agreement, calculated that diagnoses added by UnitedHealth for diseases patients had never been treated for had yielded $8.7 billion in payments to the company in 2021 – over half of its net income of $17 billion for that year.

In July 2025, the Wall Street Journal reported that United States Department of Justice officials were interviewing former UnitedHealth employees in connection with the investigation, and later that month, UnitedHealth confirmed that it was under criminal and civil federal investigation for its Medicare practices. The company said it cooperated with those probes after reaching out to the DOJ.

Change Healthcare acquisition

In February 2022, the United States Department of Justice sued to stop UnitedHealth Group's $8 billion acquisition of Change Healthcare, arguing that the deal would give UnitedHealth access to its competitors' data and ultimately push up healthcare costs. The Justice Department said that UnitedHealth knew that access to claims would give it a view into rival health plans at Humana, Anthem Inc, CVS Health, Aetna, and Cigna. A U.S. judge rejected the department's bid in September. Following the completion of the acquisition in October 2022, the parties agreed that the appeal would be voluntarily dismissed, with no reasons provided by the Justice Department for dropping the appeal.

Insider trading lawsuit

In May 2024, the City of Hollywood Firefighters Pension Fund sued UnitedHealth Group for alleged insider trading, claiming that then-Board Chair and future chairman and CEO Stephen Hemsley and then-UnitedHealthcare CEO Brian Thompson had sold millions of dollars worth of shares in UHG since October 2023 with foreknowledge that the United States Department of Justice were investigating them.

Use of algorithmic AI model to deny claims

UnitedHealth Group has faced a lawsuit over its use of an algorithmic AI model created by naviHealth, which UnitedHealth acquired in 2020, to deny claims. The lawsuit alleged that the model, named nH Predict, had a 90% error rate. A spokesperson for UnitedHealth denied that they use the model to deny claims when questioned by The Guardian.

Secret payments to nursing homes

In May 2025, The Guardian published an investigative report which uncovered a systemic effort by UnitedHealth to secretly pay nursing homes bonuses to deny hospital transfers for nursing home residents who needed immediate hospital care. Other tactics uncovered by The Guardian include UnitedHealth managers pressuring nurse practitioners to persuade members to sign onto Do not resuscitate agreements and payments for leaking confidential patient data to UnitedHealth sales teams. In June, UnitedHealth sued The Guardian for defamation over the findings of their article.

Campaign against critics

In July 2025, a New York Times investigation revealed that UnitedHealth Group, with the help of the law firm Clare Locke, had made legal threats against journalists, social media users and healthcare professionals who criticized their policies and practices. UnitedHealth also made take-down requests to social media companies hosting content critical of them.

Foundations

Foundations affiliated with UnitedHealth Group include the UnitedHealth Foundation (UHF) and the UnitedHealthcare Children's Foundation (UHCCF), both of which were established in 1999.

UHF pledged $100 million over ten years to fund scholarships and workforce development programs focused on increasing ethnic and racial diversity within the health care industry. UHF's investment will support 10,000 physicians from underrepresented communities: 5,000 students with a primary care focus and 5,000 physicians who want to advance careers in mental health, nursing, midwifery and medicine. The work of this fund is part of a broader initiative in which UnitedHealth Group has teamed up with nine organizations to provide scholarships to more than 3,000 students through the Diverse Scholars Initiative.

UHCCF administers grants to help pay for medical costs for families with coverage gaps. According to UHCCF, the foundation raises money for medical grants by selling gift items such as backpacks, books, cards, and games, some of which are created by children.

แหล่งที่มา: Wikipedia (ภาษาอังกฤษ), CC BY-SA 4.0 · ดูบน Wikipedia ↗

Wikidata ↗

UNH ภาพรวมหุ้น ราคา, มูลค่าหลักทรัพย์ตามราคาตลาด, P/E, EPS, ROE, อัตราส่วนหนี้สินต่อทุน, ช่วงราคา 52 สัปดาห์

ราคา
$397.54
มูลค่าตลาด
$360.97B
P/E (TTM)
30.1
EPS (TTM)
$13.23
รายได้ (TTM)
$447.57B
อัตราเงินปันผล
2.2%
ROE
12.0%
D/E หนี้สิน/ทุน
0.7
ช่วง 52 สัปดาห์
$256 – $462

UNH กราฟราคาหุ้น OHLCV รายวันพร้อมตัวชี้วัดทางเทคนิค — แพน ซูม และปรับแต่งมุมมองของคุณ

ผลการดำเนินงาน 10 ปี แนวโน้มรายได้ กำไรสุทธิ อัตรากำไร และ EPS

รายได้และกำไรสุทธิ $447.57B
5-point trend, +55.6%
2021-12-31 2025-12-31
EPS $13.23
5-point trend, -26.8%
2021-12-31 2025-12-31
กระแสเงินสดอิสระ $16.07B
5-point trend, -19.2%
2021-12-31 2025-12-31
อัตรากำไร 2.7%

การประเมินมูลค่า อัตราส่วน P/E, P/S, P/B, EV/EBITDA — หุ้นมีราคาแพงหรือถูก?

ตัวชี้วัด
แนวโน้ม 5 ปี
UNH
ค่ามัธยฐานของกลุ่มอุตสาหกรรม
P/E (TTM)
5-point trend, -10.2%
30.1
35.0
P/S (TTM)
5-point trend, -59.3%
0.8
0.9
P/B
5-point trend, -52.5%
3.6
3.5
EV / EBITDA
5-point trend, -12.3%
21.4
Price / FCF (ราคาต่อกระแสเงินสดอิสระ)
5-point trend, -21.7%
22.5

ความสามารถในการทำกำไร อัตรากำไรขั้นต้น, อัตรากำไรจากการดำเนินงาน และอัตรากำไรสุทธิ; ROE, ROA, ROIC

ตัวชี้วัด
แนวโน้ม 5 ปี
UNH
ค่ามัธยฐานของกลุ่มอุตสาหกรรม
Operating Margin (อัตรากำไรจากการดำเนินงาน)
5-point trend, -49.1%
4.2%
Net Profit Margin (อัตรากำไรสุทธิ)
5-point trend, -55.2%
2.7%
0.89%
ROA
5-point trend, -53.0%
4.0%
3.5%
ROE
5-point trend, -48.4%
12.0%
10.1%
ROIC
5-point trend, -39.1%
9.6%

สุขภาพทางการเงิน หนี้สิน, สภาพคล่อง, ความสามารถในการชำระหนี้ — ความแข็งแกร่งของงบดุล

ตัวชี้วัด
แนวโน้ม 5 ปี
UNH
ค่ามัธยฐานของกลุ่มอุตสาหกรรม
Debt / Equity (หนี้สินต่อทุน)
5-point trend, +17.9%
0.7
Current Ratio (อัตราส่วนสภาพคล่อง)
5-point trend, -0.1%
0.8
1.6
Quick Ratio (อัตราส่วนเงินสด)
5-point trend, -8.6%
0.4

การเติบโต การเติบโตของรายได้, EPS และกำไรสุทธิ: YoY, CAGR 3 ปี, CAGR 5 ปี

ตัวชี้วัด
แนวโน้ม 5 ปี
UNH
ค่ามัธยฐานของกลุ่มอุตสาหกรรม
Revenue YoY (รายได้ YoY)
5-point trend, +55.6%
11.8%
Revenue CAGR 3Y (CAGR รายได้ 3 ปี)
5-point trend, +55.6%
11.3%
Revenue CAGR 5Y (CAGR รายได้ 5 ปี)
5-point trend, +55.6%
11.7%
EPS YoY
5-point trend, -26.8%
-14.7%
Net Income YoY (กำไรสุทธิ YoY)
5-point trend, -30.3%
-16.3%

ตัวชี้วัดต่อหุ้น EPS, มูลค่าตามบัญชีต่อหุ้น, กระแสเงินสดต่อหุ้น, เงินปันผลต่อหุ้น

ตัวชี้วัด
แนวโน้ม 5 ปี
UNH
ค่ามัธยฐานของกลุ่มอุตสาหกรรม
EPS (Diluted) (EPS (ปรับลด))
5-point trend, -26.8%
$13.23

ประสิทธิภาพของเงินทุน อัตราหมุนเวียนสินทรัพย์, อัตราหมุนเวียนสินค้าคงคลัง, อัตราหมุนเวียนลูกหนี้

ตัวชี้วัด
แนวโน้ม 5 ปี
UNH
ค่ามัธยฐานของกลุ่มอุตสาหกรรม
Payout Ratio (อัตราการจ่ายเงินปันผล)
5-point trend, +114.9%
65.7%

เงินปันผล ผลตอบแทน, อัตราการจ่ายเงินปันผล, ประวัติเงินปันผล, CAGR 5 ปี

อัตราผลตอบแทนเงินปันผล
2.2%
อัตราการจ่ายเงินปันผล
65.7%
CAGR เงินปันผล 5 ปี
วันที่ไม่ได้รับสิทธิปันผลจำนวน
15 มิถุนายน 2026$2.3200
9 มีนาคม 2026$2.2100
8 ธันวาคม 2025$2.2100
15 กันยายน 2025$2.2100
16 มิถุนายน 2025$2.2100
10 มีนาคม 2025$2.1000
9 ธันวาคม 2024$2.1000
16 กันยายน 2024$2.1000
17 มิถุนายน 2024$2.1000
8 มีนาคม 2024$1.8800
1 ธันวาคม 2023$1.8800
8 กันยายน 2023$1.8800
15 มิถุนายน 2023$1.8800
10 มีนาคม 2023$1.6500
2 ธันวาคม 2022$1.6500
9 กันยายน 2022$1.6500
16 มิถุนายน 2022$1.6500
11 มีนาคม 2022$1.4500
3 ธันวาคม 2021$1.4500
10 กันยายน 2021$1.4500

UNH ความเห็นหลายต่อหลายของนักวิเคราะห์ มุมมองนักวิเคราะห์ทั้งเชิงบวกและเชิงลบ, ราคาเป้าหมาย 12 เดือน, อัพไซด์

ซื้อ 34 นักวิเคราะห์
  • ซื้อแนะนำ 8 23.5%
  • ซื้อ 19 55.9%
  • ถือ 7 20.6%
  • ขาย 0 0.0%
  • ขายแนะนำ 0 0.0%

ราคาเป้าหมาย 12 เดือน

26 นักวิเคราะห์ · 2026-08-15
ราคาเป้าหมายค่ามัธยฐาน $490.00 +23.3%
ราคาเป้าหมายค่าเฉลี่ย $475.23 +19.5%

ประวัติผลประกอบการ EPS จริงเทียบกับประมาณการ, เปอร์เซ็นต์ส่วนต่าง%, อัตราการชนะ, วันประกาศผลประกอบการครั้งถัดไป

ค่าเฉลี่ยส่วนต่าง
0.25%
งวด EPS Actual EPS คาด ส่วนต่าง
30 มิถุนายน 2026 $6.38 $4.95 1.4%
31 มีนาคม 2026 $7.23 $6.64 0.59%
31 ธันวาคม 2025 $2.11 $2.12 -0.01%
30 กันยายน 2025 $2.92 $2.82 0.10%
30 มิถุนายน 2025 $4.08 $4.53 -0.45%
31 มีนาคม 2025 $7.20 $7.36 -0.16%

การเปรียบเทียบกับบริษัทคู่เทียบ (อุตสาหกรรมย่อย GICS) เมตริกสำคัญเทียบกับบริษัทในกลุ่มอุตสาหกรรมเดียวกัน

Ticker มูลค่าตลาด P/E รายได้ YoY อัตรากำไรสุทธิ ROE อัตรากำไรขั้นต้น
UNH $299.08B 25.0 11.8% 2.7% 12.0%
ELV $77.37B 13.9 12.5% 2.8% 13.3%
HUM $50.90B 26.0 10.1% 0.92% 7.0%
CNC $20.24B -3.0 19.4% -3.4% -28.8% 7.3%
MOH $8.85B 19.5 11.8% 1.0% 10.9%
HQY $7.12B 34.0 9.5% 16.4% 10.1% 69.5%
ALHC $4.03B 46.1% -0.02% -0.52%
CLOV -5.1 40.3% -4.5% -26.2%
PGNY $2.14B 39.5 10.4% 4.5% 11.3% 23.6%

ปัจจัยพื้นฐานฉบับเต็ม ตัวชี้วัดทั้งหมดรายปี — งบกำไรขาดทุน, งบดุล, งบกระแสเงินสด

งบกำไรขาดทุน 14
ข้อมูล งบกำไรขาดทุน รายปีสำหรับ UNH
ตัวชี้วัด แนวโน้ม 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +243.0% $447.57B $400.28B $371.62B $324.16B $287.60B $257.14B $242.16B $226.25B $201.16B $184.84B $157.11B $130.47B
Cost of Revenue 12-point trend, +1224.0% $50.66B $46.69B $38.77B $33.70B $31.03B $30.75B $28.12B $27.00B $24.11B $24.42B $16.21B $3.83B
SG&A Expense 12-point trend, +180.3% $59.59B $53.01B $54.63B $47.78B $42.58B $41.70B $35.19B $34.07B $29.56B $28.40B $24.31B $21.26B
Operating Expenses 12-point trend, +256.6% $428.60B $367.99B $339.26B $295.73B $263.63B $234.74B $222.47B $208.90B $185.95B $171.91B $146.09B $120.20B
Operating Income 12-point trend, +84.6% $18.96B $32.29B $32.36B $28.43B $23.97B $22.41B $19.68B $17.34B $15.21B $12.93B $11.02B $10.27B
Interest Expense 12-point trend, +547.6% $4.00B $3.91B $3.25B $2.09B $1.66B $1.66B $1.70B $1.40B $1.19B $1.07B $790M $618M
Pretax Income 12-point trend, +52.2% $14.70B $20.07B $29.11B $26.34B $22.31B $20.74B $17.98B $15.94B $14.02B $11.86B $10.23B $9.66B
Income Tax 12-point trend, -53.2% $1.89B $4.83B $5.97B $5.70B $4.58B $4.97B $3.74B $3.56B $3.20B $4.79B $4.36B $4.04B
Net Income 12-point trend, +114.6% $12.06B $14.40B $22.38B $20.12B $17.29B $15.40B $13.84B $11.99B $10.56B $7.02B $5.81B $5.62B
EPS (Basic) 12-point trend, +129.8% $13.28 $15.64 $24.12 $21.47 $18.33 $16.23 $14.55 $12.45 $10.95 $7.37 $6.10 $5.78
EPS (Diluted) 12-point trend, +132.1% $13.23 $15.51 $23.86 $21.18 $18.08 $16.03 $14.33 $12.19 $10.72 $7.25 $6.01 $5.70
Shares (Basic) 12-point trend, -6.6% 908,000,000 921,000,000 928,000,000 937,000,000 943,000,000 949,000,000 951,000,000 963,000,000 964,000,000 952,000,000 953,000,000 972,000,000
Shares (Diluted) 12-point trend, -7.6% 911,000,000 929,000,000 938,000,000 950,000,000 956,000,000 961,000,000 966,000,000 983,000,000 985,000,000 968,000,000 967,000,000 986,000,000
EBITDA 12-point trend, +84.6% $18.96B $32.29B $32.36B $28.43B $23.97B $22.41B $19.68B $17.34B $15.21B $12.93B $11.02B $10.27B
งบดุล 26
ข้อมูล งบดุล รายปีสำหรับ UNH
ตัวชี้วัด แนวโน้ม 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +225.1% $24.36B $25.31B $25.43B $23.36B $21.38B $16.92B $10.98B $10.87B $11.98B $10.43B $10.92B $7.50B
Short-term Investments 12-point trend, +115.7% $3.76B $3.80B $4.20B $4.55B $2.53B $2.86B $3.26B $3.46B $3.51B $2.85B $1.99B $1.74B
Receivables 12-point trend, +441.3% $23.02B $22.36B $21.28B $17.68B $14.22B $12.87B $11.82B $11.39B $9.57B $8.15B $6.52B $4.25B
Inventory 5-point trend, +13.8% $3.30B $3.80B $2.80B $3.50B $2.90B · · · · · · ·
Prepaid Expense 12-point trend, +826.4% $9.75B $8.21B $6.08B $6.62B $5.32B $4.46B $3.85B $3.09B $2.66B $1.85B $2.41B $1.05B
Current Assets 12-point trend, +284.5% $90.58B $85.78B $78.44B $69.07B $61.76B $53.72B $42.63B $38.69B $37.08B $33.88B $31.64B $23.56B
PP&E (Net) 12-point trend, +143.6% $10.76B $10.55B $11.45B $10.13B $8.97B $8.63B $8.70B $8.46B $7.01B $5.90B $4.86B $4.42B
Accum. Depreciation 12-point trend, +155.5% $7.55B $6.97B $7.04B $6.93B $5.99B $5.23B $5.00B $4.14B $3.69B $3.75B $3.17B $2.95B
Goodwill 12-point trend, +235.5% $110.50B $106.73B $103.73B $93.35B $75.80B $71.34B $65.66B $58.91B $54.56B $47.58B $44.45B $32.94B
Intangibles 12-point trend, +458.0% $20.47B $23.27B $15.19B $14.40B $10.04B $10.86B $10.35B $9.32B $8.49B $8.54B $8.39B $3.67B
Other Non-current Assets 12-point trend, +674.3% $23.01B $19.59B $17.30B $15.03B $12.53B $11.51B $9.33B $4.33B $3.58B $3.04B $3.12B $2.97B
Total Assets 12-point trend, +258.7% $309.58B $298.28B $273.72B $245.71B $212.21B $197.29B $173.89B $152.22B $139.06B $122.81B $111.25B $86.30B
Accounts Payable 12-point trend, +311.3% $38.03B $34.34B $31.96B $27.71B $24.64B $22.50B $19.00B $16.70B $15.18B $13.36B $11.99B $9.25B
Current Liabilities 12-point trend, +275.2% $114.90B $103.77B $99.05B $89.24B $78.29B $72.42B $61.78B $53.21B $50.46B $49.25B $42.90B $30.62B
Deferred Tax 12-point trend, +17.2% $2.42B $3.62B $3.02B $2.77B $3.27B $3.37B $2.99B $2.47B $2.18B $2.76B $3.59B $2.06B
Other Non-current Liabilities 12-point trend, +1244.5% $18.25B $15.94B $14.46B $12.84B $11.79B $12.31B $10.14B $5.73B $5.56B $4.83B $1.48B $1.36B
Total Liabilities 12-point trend, +295.7% $207.88B $195.69B $174.80B $159.36B $135.73B $126.75B $111.73B $95.99B $87.04B $82.62B $75.79B $52.54B
Long-term Debt 8-point trend, +164.3% · · · · $46.00B $43.47B $40.68B $36.55B $31.69B $32.97B $31.96B $17.41B
Total Debt 12-point trend, +315.5% $72.32B $72.36B $58.26B $54.51B $46.00B $43.47B $40.68B $36.55B $31.69B $32.97B $32.09B $17.41B
Common Stock 12-point trend, -10.0% $9M $9M $9M $9M $10M $10M $9M $10M $10M $10M $10M $10M
Paid-in Capital 11-point trend, +559000000.00 $559M $0 $0 · $0 $0 $7M $0 $1.70B $0 $29M $0
Retained Earnings 12-point trend, +182.5% $95.60B $96.04B $95.77B $86.16B $77.13B $69.30B $61.18B $55.85B $48.73B $40.95B $37.12B $33.84B
AOCI 12-point trend, -48.1% $-2.06B $-3.39B $-7.03B $-8.39B $-5.38B $-3.81B $-3.58B $-4.16B $-2.67B $-2.68B $-3.33B $-1.39B
Stockholders' Equity 12-point trend, +208.4% $100.09B $98.27B $94.42B $81.45B $75.05B $68.33B $60.44B $54.32B $49.83B $38.18B $33.73B $32.45B
Liabilities + Equity 12-point trend, +258.4% $309.58B $298.28B $273.72B $245.71B $212.21B $197.29B $173.89B $152.22B $139.06B $122.81B $111.25B $86.38B
Shares Outstanding 12-point trend, -5.0% 906,000,000 915,000,000 924,000,000 934,000,000 941,000,000 946,000,000 948,000,000 960,000,000 969,000,000 952,000,000 953,000,000 954,000,000
กระแสเงินสด 18
ข้อมูล กระแสเงินสด รายปีสำหรับ UNH
ตัวชี้วัด แนวโน้ม 202520242023202220212020201920182017201620152014
D&A 12-point trend, +195.1% $4.36B $4.10B $3.97B $3.40B $3.10B $2.89B $2.72B $2.43B $2.25B $2.06B $1.69B $1.48B
Stock-based Comp 12-point trend, +166.8% $971M $1.02B $1.06B $925M $800M $679M $697M $638M $597M $485M $406M $364M
Deferred Tax 12-point trend, -1397.4% $-1.75B $-296M $-245M $-673M $130M $-8M $230M $42M $-965M $81M $-73M $-117M
Amort. of Intangibles 12-point trend, +224.4% $1.70B $1.70B $1.60B $1.30B $1.20B $1.10B $1.00B $898M $896M $882M $650M $524M
Operating Cash Flow 12-point trend, +144.7% $19.70B $24.20B $29.07B $26.21B $22.34B $22.17B $18.46B $15.71B $13.60B $9.79B $9.74B $8.05B
CapEx 12-point trend, +137.5% $3.62B $3.50B $3.39B $2.80B $2.45B $2.05B $2.07B $2.06B $2.02B $1.71B $1.56B $1.52B
Investing Cash Flow 12-point trend, -242.7% $-8.69B $-20.53B $-15.57B $-28.48B $-10.37B $-12.53B $-12.70B $-12.38B $-8.60B $-9.36B $-18.39B $-2.53B
Debt Issued 12-point trend, +48.7% $2.97B $17.81B $6.39B $14.82B $6.93B $4.86B $5.44B $6.93B $5.29B $3.97B $11.98B $2.00B
Net Debt Issued 12-point trend, -106.8% $-81M $14.81B $4.27B $11.80B $3.78B $1.71B $3.69B $4.33B $893M $1.37B $10.94B $1.19B
Stock Issued 12-point trend, +79.0% $827M $1.85B $1.35B $1.25B $1.35B $1.44B $1.04B $838M $688M $429M $402M $462M
Stock Repurchased 12-point trend, +38.3% $5.54B $9.00B $8.00B $7.00B $5.00B $4.25B $5.50B $4.50B $1.50B $1.28B $1.20B $4.01B
Net Stock Activity 12-point trend, -33.1% $-4.72B $-7.15B $-6.65B $-5.75B $-3.65B $-2.81B $-4.46B $-3.66B $-812M $-851M $-798M $-3.55B
Dividends Paid 12-point trend, +481.2% $7.92B $7.53B $6.76B $5.99B $5.28B $4.58B $3.93B $3.32B $2.77B $2.26B $1.79B $1.36B
Financing Cash Flow 12-point trend, -120.0% $-11.64B $-3.51B $-11.53B $4.23B $-7.46B $-3.59B $-5.62B $-4.37B $-3.44B $-1.01B $12.24B $-5.29B
Net Change in Cash 12-point trend, -532.4% $-947M $-115M $2.06B $1.99B $4.45B $5.94B $119M $-1.11B $1.55B $-493M $3.43B $219M
Taxes Paid 12-point trend, -7.7% $3.71B $4.62B $6.08B $5.22B $3.97B $4.93B $3.54B $3.26B $4.00B $4.73B $4.40B $4.02B
Free Cash Flow 12-point trend, +146.3% $16.07B $20.70B $25.68B $23.40B $19.89B $20.12B $16.39B $13.65B $11.57B $8.09B $8.18B $6.53B
Levered FCF 12-point trend, +104.1% $12.59B $17.74B $23.10B $21.76B $18.57B $18.86B $15.04B $12.56B $10.66B $7.45B $7.73B $6.17B
ความสามารถในการทำกำไร 7
ข้อมูล ความสามารถในการทำกำไร รายปีสำหรับ UNH
ตัวชี้วัด แนวโน้ม 202520242023202220212020201920182017201620152014
Operating Margin 12-point trend, -46.1% 4.2% 8.1% 8.7% 8.8% 8.3% 8.7% 8.1% 7.7% 7.6% 7.0% 7.0% 7.9%
Net Margin 12-point trend, -37.6% 2.7% 3.6% 6.0% 6.2% 6.0% 6.0% 5.7% 5.3% 5.2% 3.8% 3.7% 4.3%
Pretax Margin 12-point trend, -55.7% 3.3% 5.0% 7.8% 8.1% 7.8% 8.1% 7.4% 7.0% 7.0% 6.4% 6.5% 7.4%
EBITDA Margin 12-point trend, -46.1% 4.2% 8.1% 8.7% 8.8% 8.3% 8.7% 8.1% 7.7% 7.6% 7.0% 7.0% 7.9%
ROA 12-point trend, -40.6% 4.0% 4.8% 8.6% 8.8% 8.4% 8.3% 8.5% 8.2% 8.1% 6.0% 5.9% 6.7%
ROE 12-point trend, -30.4% 12.0% 14.5% 24.3% 25.2% 23.3% 22.6% 23.4% 22.4% 21.7% 18.5% 17.4% 17.3%
ROIC 12-point trend, -20.1% 9.6% 14.4% 16.9% 16.4% 15.7% 15.2% 15.4% 14.8% 14.4% 10.8% 9.6% 12.0%
สภาพคล่องและความสามารถในการชำระหนี้ 5
ข้อมูล สภาพคล่องและความสามารถในการชำระหนี้ รายปีสำหรับ UNH
ตัวชี้วัด แนวโน้ม 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, +2.5% 0.8 0.8 0.8 0.8 0.8 0.7 0.7 0.7 0.7 0.7 0.7 0.8
Quick Ratio 12-point trend, +1.0% 0.4 0.5 0.5 0.5 0.5 0.5 0.4 0.5 0.5 0.4 0.5 0.4
Debt / Equity 12-point trend, +34.7% 0.7 0.7 0.6 0.7 0.6 0.6 0.7 0.7 0.6 0.9 1.0 0.5
LT Debt / Equity 12-point trend, +46.5% 0.7 0.7 0.6 0.7 0.6 0.6 0.6 0.6 0.6 0.7 0.8 0.5
Interest Coverage 12-point trend, -71.5% 4.7 8.3 10.0 13.6 14.4 13.5 11.6 12.4 12.8 12.1 14.0 16.6
ประสิทธิภาพ 3
ข้อมูล ประสิทธิภาพ รายปีสำหรับ UNH
ตัวชี้วัด แนวโน้ม 202520242023202220212020201920182017201620152014
Asset Turnover 12-point trend, -5.0% 1.5 1.3 1.4 1.4 1.4 1.4 1.5 1.6 1.5 1.6 1.6 1.6
Inventory Turnover 4-point trend, +35.5% 14.3 14.1 12.3 10.5 · · · · · · · ·
Receivables Turnover 12-point trend, -44.8% 19.7 18.3 19.1 20.3 21.2 20.8 20.9 21.6 22.7 25.2 29.2 35.7
ต่อหุ้น 7
ข้อมูล ต่อหุ้น รายปีสำหรับ UNH
ตัวชี้วัด แนวโน้ม 202520242023202220212020201920182017201620152014
Book Value / Share 12-point trend, +224.7% $110.47 $107.40 $102.19 $87.21 $79.75 $72.23 $63.75 $56.58 $51.43 $40.10 $35.39 $34.02
Revenue / Share 12-point trend, +271.3% $491.29 $430.87 $396.19 $341.22 $300.83 $267.58 $250.68 $230.16 $204.22 $190.95 $162.47 $132.33
Cash Flow / Share 12-point trend, +164.8% $21.62 $26.05 $30.99 $27.59 $23.37 $23.07 $19.11 $15.98 $13.80 $10.12 $10.07 $8.17
Cash / Share 12-point trend, +242.3% $26.89 $27.66 $27.52 $25.02 $22.72 $17.89 $11.59 $11.32 $12.36 $10.96 $11.46 $7.86
Dividend / Share 4-point trend, +104.6% · · · · · · · · $3 $2 $2 $1
Dividend Paid / Share 12-point trend, +521.4% $9 $8 $7 $6 $6 $5 $4 $3 $3 $2 $2 $1
EPS (TTM) 12-point trend, +132.1% $13.23 $15.51 $23.86 $21.18 $18.08 $16.03 $14.33 $12.19 $10.72 $7.25 $6.01 $5.70
อัตราการเติบโต 10
ข้อมูล อัตราการเติบโต รายปีสำหรับ UNH
ตัวชี้วัด แนวโน้ม 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -0.3% 11.8% 7.7% 14.6% 12.7% 11.8% · · · · · · ·
Revenue CAGR 3Y 3-point trend, -13.1% 11.3% 11.7% 13.1% · · · · · · · · ·
Revenue CAGR 5Y 11.7% · · · · · · · · · · ·
EPS YoY 5-point trend, -214.9% -14.7% -35.0% 12.7% 17.2% 12.8% · · · · · · ·
EPS CAGR 3Y 3-point trend, -202.4% -14.5% -5.0% 14.2% · · · · · · · · ·
EPS CAGR 5Y -3.8% · · · · · · · · · · ·
Net Income YoY 5-point trend, -233.5% -16.3% -35.6% 11.2% 16.4% 12.2% · · · · · · ·
Net Income CAGR 3Y 3-point trend, -218.3% -15.7% -5.9% 13.3% · · · · · · · · ·
Net Income CAGR 5Y -4.8% · · · · · · · · · · ·
Dividend CAGR 5Y 11.6% · · · · · · · · · · ·
การประเมินมูลค่า (TTM) 16
ข้อมูล การประเมินมูลค่า (TTM) รายปีสำหรับ UNH
ตัวชี้วัด แนวโน้ม 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +243.0% $447.57B $400.28B $371.62B $324.16B $287.60B $257.14B $242.16B $226.25B $201.16B $184.84B $157.11B $130.47B
Net Income TTM 12-point trend, +114.6% $12.06B $14.40B $22.38B $20.12B $17.29B $15.40B $13.84B $11.99B $10.56B $7.02B $5.81B $5.62B
Market Cap 12-point trend, +210.1% $299.08B $462.86B $486.46B $495.19B $472.51B $331.74B $278.69B $239.16B $213.63B $152.36B $112.11B $96.44B
Enterprise Value 12-point trend, +228.2% $343.28B $506.11B $515.09B $521.79B $494.61B $355.43B $305.13B $261.39B $229.83B $172.05B $131.29B $104.61B
P/E 12-point trend, +40.7% 25.0 32.6 22.1 25.0 27.8 21.9 20.5 20.4 20.6 22.1 19.6 17.7
P/S 12-point trend, -9.6% 0.7 1.2 1.3 1.5 1.6 1.3 1.2 1.1 1.1 0.8 0.7 0.7
P/B 12-point trend, +0.6% 3.0 4.7 5.2 6.1 6.3 4.9 4.6 4.4 4.3 4.0 3.3 3.0
P / Cash Flow 12-point trend, +26.8% 15.2 19.1 16.7 18.9 21.1 15.0 15.1 15.2 15.7 15.6 11.5 12.0
P / FCF 12-point trend, +25.9% 18.6 22.4 18.9 21.2 23.8 16.5 17.0 17.5 18.5 18.8 13.7 14.8
EV / EBITDA 12-point trend, +77.8% 18.1 15.7 15.9 18.4 20.6 15.9 15.5 15.1 15.1 13.3 11.9 10.2
EV / FCF 12-point trend, +33.2% 21.4 24.4 20.1 22.3 24.9 17.7 18.6 19.1 19.9 21.3 16.0 16.0
EV / Revenue 12-point trend, -4.3% 0.8 1.3 1.4 1.6 1.7 1.4 1.3 1.2 1.1 0.9 0.8 0.8
Dividend Yield 12-point trend, +87.9% 2.6% 1.6% 1.4% 1.2% 1.1% 1.4% 1.4% 1.4% 1.3% 1.5% 1.6% 1.4%
Earnings Yield 12-point trend, -28.9% 4.0% 3.1% 4.5% 4.0% 3.6% 4.6% 4.9% 4.9% 4.9% 4.5% 5.1% 5.6%
Payout Ratio 12-point trend, +170.9% 65.7% 52.3% 30.2% 29.8% 30.6% 29.8% 28.4% 27.7% 26.3% 32.2% 30.7% 24.2%
Annual Payout 12-point trend, +481.2% $7.92B $7.53B $6.76B $5.99B $5.28B $4.58B $3.93B $3.32B $2.77B $2.26B $1.79B $1.36B

งบการเงิน งบกำไรขาดทุน, งบดุล, งบกระแสเงินสด — รายปี, 5 ปีล่าสุด

งบกำไรขาดทุน
2025-12-312025-06-302025-03-312024-12-312024-09-30
รายได้ $447.57B$400.28B
อัตรากำไรจากการดำเนินงาน % 4.2%8.1%
กำไรสุทธิ $12.06B$14.40B
EPS ที่ปรับลดแล้ว $13.23$15.51
งบดุล
2025-12-312025-06-302025-03-312024-12-312024-09-30
หนี้สินต่อทุน 0.70.7
อัตราส่วนสภาพคล่อง 0.80.8
อัตราส่วนเงินสด 0.40.5
กระแสเงินสด
2025-12-312025-06-302025-03-312024-12-312024-09-30
กระแสเงินสดอิสระ $16.07B$20.70B

ข่าวล่าสุด หัวข้อข่าวล่าสุดที่กล่าวถึงบริษัทนี้

สัญญาณซื้อขาย สัญญาณซื้อ/ขายล่าสุดพร้อมราคาเข้าและอัตราส่วนความเสี่ยง/ผลตอบแทน

ตัวชี้วัดของฉัน รายการเฝ้าดูส่วนตัวของคุณ — แถวที่เลือกจากข้อมูลพื้นฐานฉบับเต็ม

📊

เลือกเมตริกที่สำคัญสำหรับคุณ — คลิก ➕ ถัดจากแถวใดก็ได้ในข้อมูลพื้นฐานฉบับเต็มด้านบน

การเลือกของคุณถูกบันทึกและจะติดตามคุณไปในทุกสัญลักษณ์หุ้น

ผู้ถือครองสถาบัน (13F) 3,752 รายงาน · $243.5B ทั้งหมด · ณ วันที่ 30 มิถุนายน 2026

สถาบันที่รายงานการถือครองหุ้นนี้ในเอกสาร SEC Form 13F รายไตรมาสของตน เฉพาะสถานะ Long; ผู้ยื่นคำร้องรายเดียวอาจปรากฏสองครั้งสำหรับสัญญาออปชันที่แยกจากกัน ขา put/call ขนาดใหญ่ที่หักล้างกันมักสะท้อนถึงการทำตลาด (market-making) หรือสินค้าคงคลังที่มีการป้องกันความเสี่ยง (hedged inventory) ไม่ใช่การเชื่อมั่นในทิศทาง

กิจกรรมของผู้ลงทุนสถาบัน — Q2 2026 เทียบกับไตรมาสก่อนหน้า
พอร์ตใหม่ ตำแหน่งที่ปิดไปแล้ว เพิ่มขึ้น ลดลง การเปลี่ยนแปลงสุทธิของจำนวนหุ้น
513 (+264 เทียบกับไตรมาสก่อน) 121 (-257 เทียบกับไตรมาสก่อน) 1,267 (+54 เทียบกับไตรมาสก่อน) 1,278 (-102 เทียบกับไตรมาสก่อน) +117.7M

เปรียบเทียบกับ Q1 2026. การยื่นแบบฟอร์ม 13F ของ SEC จะครบกำหนดภายใน 45 วันนับจากสิ้นสุดไตรมาส บวกกับระยะเวลาผ่อนผันสั้นๆ สำหรับผู้ยื่นล่าช้า — ไตรมาสที่ยังอยู่ในช่วงเวลานี้จะถูกข้ามไปเพื่อใช้คู่ที่รายงานล่าสุดอย่างสมบูรณ์

สถาบัน มูลค่า หุ้น % ของ 13F ที่ติดตาม ประเภท
VANGUARD GROUP INC $27,207,979,474 82,420,949 11.17% หุ้น
VANGUARD CAPITAL MANAGEMENT LLC $24,651,649,136 59,311,525 10.12% หุ้น
STATE STREET CORP $18,966,554,763 45,633,267 7.79% หุ้น
Capital World Investors $12,422,776,956 29,887,932 5.10% หุ้น
VANGUARD PORTFOLIO MANAGEMENT LLC $10,175,966,547 24,483,234 4.18% หุ้น
GEODE CAPITAL MANAGEMENT, LLC $7,770,611,877 18,774,463 3.19% หุ้น
FMR LLC $7,185,101,298 17,287,254 2.95% หุ้น
NORGES BANK $5,293,868,088 12,736,973 2.17% หุ้น
Capital Research Global Investors $4,378,631,657 10,534,177 1.80% หุ้น
WELLINGTON MANAGEMENT GROUP LLP $4,210,086,678 10,129,410 1.73% หุ้น
Fisher Asset Management, LLC $3,774,863,715 9,082,269 1.55% หุ้น
Dodge & Cox $3,770,702,593 9,072,258 1.55% หุ้น
Capital International Investors $3,237,872,783 7,789,028 1.33% หุ้น
JANE STREET GROUP, LLC $3,165,978,399 7,617,300 1.30% สัญญาซื้อล่วงหน้า
Sanders Capital, LLC $2,451,649,249 5,898,634 1.01% หุ้น
EAGLE CAPITAL MANAGEMENT LLC $2,399,442,912 5,773,026 0.99% หุ้น
VANGUARD FIDUCIARY TRUST CO $2,119,167,278 5,098,687 0.87% หุ้น
ALLIANCEBERNSTEIN L.P. $2,075,268,358 7,669,420 0.85% หุ้น
MORGAN STANLEY $2,055,731,816 4,946,062 0.84% หุ้น
JANE STREET GROUP, LLC $2,055,124,098 4,944,600 0.84% สัญญาขายล่วงหน้า
DIMENSIONAL FUND ADVISORS LP $1,717,292,161 4,131,778 0.71% หุ้น
BNP PARIBAS FINANCIAL MARKETS $1,526,781,892 3,673,416 0.63% หุ้น
AMERIPRISE FINANCIAL INC $1,405,176,851 3,380,319 0.58% หุ้น
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $1,251,138,985 3,010,223 0.51% หุ้น
Grantham, Mayo, Van Otterloo & Co. LLC $1,174,164,878 2,825,022 0.48% หุ้น
BlackRock, Inc. $1,158,005,862 2,786,146 0.48% หุ้น
UBS Group AG $1,092,471,817 2,628,472 0.45% สัญญาซื้อล่วงหน้า
BANK OF AMERICA CORP /DE/ $1,087,853,337 2,617,360 0.45% หุ้น
Mitsubishi UFJ Asset Management Co., Ltd. $1,065,664,884 2,563,973 0.44% หุ้น
Swiss National Bank $1,064,029,841 2,560,041 0.44% หุ้น
Sumitomo Mitsui Trust Group, Inc. $1,055,107,927 2,538,575 0.43% หุ้น
CANADA PENSION PLAN INVESTMENT BOARD $971,757,071 2,338,034 0.40% หุ้น
BARCLAYS PLC $897,842,266 2,160,196 0.37% หุ้น
RAYMOND JAMES FINANCIAL INC $874,984,816 2,105,201 0.36% หุ้น
Walleye Trading LLC $861,060,671 2,071,700 0.35% สัญญาขายล่วงหน้า
MANUFACTURERS LIFE INSURANCE COMPANY, THE $860,919,095 2,071,359 0.35% หุ้น
VANGUARD ASSET MANAGEMENT, Ltd $847,773,811 2,039,732 0.35% หุ้น
Walleye Trading LLC $845,183,605 2,033,500 0.35% สัญญาซื้อล่วงหน้า
Vanguard Global Advisers, LLC $819,257,021 1,971,121 0.34% หุ้น
National Pension Service $818,929,089 1,970,332 0.34% หุ้น
WOLVERINE TRADING, LLC $815,453,232 2,362,400 0.33% สัญญาซื้อล่วงหน้า
ENVESTNET ASSET MANAGEMENT INC $811,129,699 1,951,573 0.33% หุ้น
California Public Employees Retirement System $799,750,674 1,924,189 0.33% หุ้น
Pentwater Capital Management LP $777,228,100 1,870,000 0.32% สัญญาซื้อล่วงหน้า
Legal & General Group Plc $771,950,431 1,857,302 0.32% หุ้น
HSBC HOLDINGS PLC $751,372,125 1,802,500 0.31% สัญญาขายล่วงหน้า
MILLENNIUM MANAGEMENT LLC $672,345,116 1,617,653 0.28% หุ้น
GOLDMAN SACHS GROUP INC $636,389,783 1,531,145 0.26% หุ้น
MARSHFIELD ASSOCIATES $634,316,697 1,526,157 0.26% หุ้น
UBS Group AG $621,815,730 1,496,080 0.26% หุ้น
RHUMBLINE ADVISERS $607,608,189 1,461,895 0.25% หุ้น
Ensign Peak Advisors, Inc $599,888,338 1,443,323 0.25% หุ้น
Qube Research & Technologies Ltd $584,349,595 1,405,937 0.24% หุ้น
Caisse de depot et placement du Quebec $566,755,977 1,363,607 0.23% หุ้น
AMERICAN CENTURY COMPANIES INC $566,576,841 1,363,176 0.23% หุ้น
Assenagon Asset Management S.A. $542,834,808 1,306,053 0.22% หุ้น
1832 Asset Management L.P. $537,572,517 1,293,392 0.22% หุ้น
LPL Financial LLC $531,650,741 1,279,144 0.22% หุ้น
Davis Selected Advisers $529,839,298 1,274,650 0.22% หุ้น
FARALLON CAPITAL MANAGEMENT, L.L.C. $528,071,215 1,270,532 0.22% หุ้น
WOLVERINE TRADING, LLC $512,799,408 1,485,600 0.21% สัญญาขายล่วงหน้า
HSBC HOLDINGS PLC $508,842,509 1,224,268 0.21% หุ้น
FIL Ltd $462,416,638 1,112,568 0.19% หุ้น
ADAGE CAPITAL PARTNERS GP, L.L.C. $461,418,710 1,110,167 0.19% หุ้น
Ninety One UK Ltd $458,593,637 1,103,370 0.19% หุ้น
SUSQUEHANNA INTERNATIONAL GROUP, LLP $456,902,059 1,099,300 0.19% สัญญาซื้อล่วงหน้า
Nuveen Asset Management, LLC $449,500,757 888,587 0.18% หุ้น
Veritas Asset Management LLP $448,132,682 1,078,201 0.18% หุ้น
NAYA CAPITAL MANAGEMENT UK LTD $436,832,118 1,051,012 0.18% หุ้น
NEUBERGER BERMAN GROUP LLC $435,590,401 1,047,589 0.18% หุ้น
MACKENZIE FINANCIAL CORP $431,689,943 1,038,640 0.18% หุ้น
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC $430,280,958 1,035,250 0.18% หุ้น
CTC LLC $424,566,045 10,215 0.17% สัญญาขายล่วงหน้า
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $411,538,954 990,157 0.17% หุ้น
NEW YORK STATE COMMON RETIREMENT FUND $408,705,604 983,340 0.17% หุ้น
JANE STREET GROUP, LLC $402,713,051 968,922 0.17% หุ้น
CITADEL ADVISORS LLC $400,319,438 963,163 0.16% หุ้น
CTC LLC $395,596,634 9,518 0.16% สัญญาซื้อล่วงหน้า
Fayez Sarofim & Co $394,573,729 949,339 0.16% หุ้น
D. E. Shaw & Co., Inc. $382,462,726 920,200 0.16% สัญญาขายล่วงหน้า
GOLDMAN SACHS GROUP INC $375,355,453 903,100 0.15% สัญญาขายล่วงหน้า
MILLENNIUM MANAGEMENT LLC $372,529,169 896,300 0.15% สัญญาขายล่วงหน้า
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $366,901,369 1,355,931 0.15% หุ้น
Allen Investment Management, LLC $364,199,528 876,259 0.15% หุ้น
FIRST MANHATTAN CO. LLC. $360,530,629 867,432 0.15% หุ้น
PRUDENTIAL FINANCIAL INC $359,505,403 864,965 0.15% หุ้น
Longview Partners (Guernsey) LTD $350,167,028 842,497 0.14% หุ้น
W1M Asset Management Ltd $349,962,345 842,562 0.14% หุ้น
AVIVA PLC $347,327,444 835,665 0.14% หุ้น
Point72 Asset Management, L.P. $345,328,264 830,855 0.14% หุ้น
TD Asset Management Inc $337,496,548 812,012 0.14% หุ้น
TORONTO DOMINION BANK $337,017,326 810,859 0.14% หุ้น
PineStone Asset Management Inc. $335,630,369 807,522 0.14% หุ้น
JENNISON ASSOCIATES LLC $335,325,296 806,788 0.14% หุ้น
PeakShares LLC $329,595,000 793 0.14% หุ้น
US BANCORP \DE\ $328,365,156 790,042 0.13% หุ้น
JONES FINANCIAL COMPANIES LLLP $325,830,242 761,481 0.13% หุ้น
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $320,418,726 770,923 0.13% หุ้น
Clearbridge Investments, LLC $312,811,372 752,620 0.13% หุ้น
Robeco Institutional Asset Management B.V. $311,375,867 749,166 0.13% หุ้น

ผู้บริหารบริษัท 64 รายชื่อผู้บริหาร · ผู้บริหาร 37 คน · กรรมการ 27 คน

ผู้บริหารภายใน บทบาท กิจกรรมล่าสุด หุ้นที่ถือครอง ซื้อ 12 เดือน ขาย 12 เดือน สุทธิ 12 เดือน
Timothy John Noel Chief Executive Officer, UHC 23 มิถุนายน 2026 A 17,651 0 0 $0
Stephen J Hemsley CEO, UHG 23 มิถุนายน 2026 A 48,099 0 0 $0
Heather Cianfrocco Chief Executive Officer, Optum 18 มีนาคม 2025 A 22,438 0 0 $0
Andrew Witty CEO, UHG 18 มีนาคม 2025 A 112,162 0 0 $0
Brian R Thompson CEO, UnitedHealthcare 24 กันยายน 2024 A 32,675 0 0 $0
David S Wichmann Chief Executive Officer 16 ธันวาคม 2020 F 967,872 0 0 $0
Steven H Nelson EVP & CEO, UnitedHealthcare 25 มิถุนายน 2019 A 38,502 0 0 $0
Larry C Renfro Vice Chmn, UHG and CEO, Optum 26 มิถุนายน 2018 A 153,790 0 0 $0
Gail Boudreaux EVP & CEO, UnitedHealthcare 23 กันยายน 2014 A 184,732 0 0 $0
George Lawrence Mikan III EVP UHG & CEO, Optum 5 มิถุนายน 2011 F 209,279 0 0 $0
Tracy L Bahl CEO, Uniprise 7 พฤศจิกายน 2006 A 4,230 0 0 $0
Robert J Sheehy CEO, UnitedHealthcare 7 พฤศจิกายน 2006 A 3,009 0 0 $0
MCGUIRE WILLIAM W Chief Executive Officer 7 พฤศจิกายน 2006 A 644,862 0 0 $0
Channing R Wheeler CEO, Uniprise, Inc. 28 พฤศจิกายน 2003 J 8,356 0 0 $0
Wayne S Deveydt Chief Financial Officer 23 มิถุนายน 2026 A 19,779 0 0 $0
John F Rex President & CFO 24 มิถุนายน 2025 A 203,898 0 0 $0
Patrick J Erlandson Chief Financial Officer 2 พฤษภาคม 2006 A 7,083 0 0 $0
Dirk C Mcmahon President & COO, UHG 19 มีนาคม 2024 A 70,547 0 0 $0
Christopher R Zaetta EVP & Chief Legal Officer 23 มิถุนายน 2026 A 15,860 0 0 $0
Erin Mcsweeney EVP & Chief People Officer 23 มิถุนายน 2026 A 15,601 0 0 $0
Thomas E Roos Chief Accounting Officer 23 กุมภาพันธ์ 2026 A 31,284 0 0 $0
Rupert M Bondy EVP & Chief Legal Officer 19 มีนาคม 2024 A 9,607 0 0 $0
Marianne D Short EVP & Chief Legal Officer 25 กุมภาพันธ์ 2022 F 138,315 0 0 $0
Patricia L Lewis EVP and Chief HR Officer 13 กุมภาพันธ์ 2022 F 8,901 0 0 $0
Ellen D Wilson Executive Vice President 24 มีนาคม 2020 A 58,387 0 0 $0
Eric S Rangen Sr VP & Chief Acctg Officer 24 มิถุนายน 2015 A 11,577 0 0 $0
Lori Sweere EVP, Human Capital 10 พฤษภาคม 2013 S 70,661 0 0 $0
Richard N Baer EVP & Chief Legal Officer 28 ธันวาคม 2012 F 63,880 0 0 $0
Reed Vaughn Tuckson EVP & Chief of Medical Affairs 5 มิถุนายน 2012 F 116,886 0 0 $0
William A Munsell EVP, UnitedHealth Group 5 มิถุนายน 2012 F 268,167 0 0 $0
Anthony Welters EVP, UnitedHealth Group 5 มิถุนายน 2012 F 119,909 0 0 $0
Christopher James Walsh EVP and General Counsel 24 พฤษภาคม 2011 A 101,338 0 0 $0
Mitchell Eliot Zamoff EVP and General Counsel 24 พฤษภาคม 2011 A 113,613 0 0 $0
Thomas L Strickland EVP & Chief Legal Officer 5 มิถุนายน 2008 A 147,182 0 0 $0
Richard H Anderson EVP, Pres, Commercial Svcs Grp 28 พฤษภาคม 2007 A 40,606 0 0 $0
Lois E Quam EVP & Pres, Pub & Sr Mkt Grp 28 พฤษภาคม 2007 A 13,915 0 0 $0
Forrest Gregory Burke Acting General Counsel 17 เมษายน 2007 A 0 0 $0
Frederick William Mcnabb III กรรมการ 1 กรกฎาคม 2026 A 15,462 0 0 $0
Kristen Gil กรรมการ 1 กรกฎาคม 2026 A 2,617 0 0 $0
Rice Valerie Montgomery MD กรรมการ 1 กรกฎาคม 2026 A 7,876 0 0 $0
John H Noseworthy กรรมการ 1 กรกฎาคม 2026 A 7,616 0 0 $0
Charles D. Baker กรรมการ 1 กรกฎาคม 2026 A 2,396 0 1 $-9,613
Timothy Patrick Flynn กรรมการ 1 กรกฎาคม 2026 A 10,875 0 0 $0
Scott Gottlieb กรรมการ 1 กรกฎาคม 2026 A 659 0 0 $0
Paul R Garcia กรรมการ 1 กรกฎาคม 2026 A 3,906 0 0 $0
Michele J Hooper กรรมการ 1 เมษายน 2026 A 41,792 0 0 $0
BURKE RICHARD T กรรมการ 19 พฤษภาคม 2022 S 1,215,000 0 0 $0
Gail R Wilensky กรรมการ 22 มีนาคม 2022 A 24,590 0 0 $0
Glenn M Renwick กรรมการ 1 เมษายน 2021 A 85,130 0 0 $0
BALLARD WILLIAM C JR กรรมการ 1 เมษายน 2020 A 62,266 0 0 $0

ผู้บริหารจากเอกสาร SEC Form 3/4/5; สุทธิ = เฉพาะการซื้อขายในตลาดเปิด

นักเคลื่อนไหวและเจ้าของ %+ 5 2 รายการ

นักลงทุนที่ยื่น SEC Schedule 13D — กรรมสิทธิ์ตามผลประโยชน์ที่แท้จริงสูงกว่า % 5 โดยมีเจตนาที่จะมีอิทธิพลต่อผู้ออกหลักทรัพย์ (การถือหุ้นของนักเคลื่อนไหว, การรณรงค์ในคณะกรรมการ, M&A) แต่ละแถวแสดงสถานะล่าสุดที่ทราบของตำแหน่งของผู้ยื่นคำร้องรายนั้น

ผู้ยื่นคำร้อง ยื่นแล้ว ส่วนได้เสีย สถานะ วัตถุประสงค์ การยื่นคำร้อง
UnitedHealth Group Incorporated ×3 เอกสารยื่นคำร้อง 15 มกราคม 2021 การยื่นคำร้องครั้งแรก SEC
Ingenix, Inc., UnitedHealth Group Incorporated 5 มิถุนายน 2006 การยื่นคำร้องครั้งแรก SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

การถือครอง ETF ถือโดย ETF 268 ราย

น้ำหนักสะท้อนถึงการถือครองหุ้นโดยตรง (N-PORT) เท่านั้น กองทุนเลเวอเรจหรือกองทุนที่อิงตราสารอนุพันธ์อาจมีการเปิดรับความเสี่ยงจากสัญญาแลกเปลี่ยน (swap) เพิ่มเติมซึ่งไม่แสดง

กองทุน น้ำหนัก หน่วย ณ วันที่ แหล่งที่มา
IHF · iShares Trust 21.13% 647,431 SH 8 สิงหาคม 2026 รายวัน
DJD · Invesco Exchange-Traded Fund Trust 8.15% 99,571 SH 8 สิงหาคม 2026 รายวัน
IYH · iShares Trust 5.93% 540,690 SH 8 สิงหาคม 2026 รายวัน
JDOC · J.P. Morgan Exchange-Traded Fund Tr… 5.83% 1,751 NS 30 เมษายน 2026 N-PORT
VHT · VANGUARD WORLD FUND 5.56% 2,728,542 SH 8 สิงหาคม 2026 รายวัน
FHLC · FIDELITY COVINGTON TRUST 5.42% 417,583 NS 30 เมษายน 2026 N-PORT
HRTS · Tema ETF Trust 5.24% 7,159 NS 31 พฤษภาคม 2026 N-PORT
FLAG · Global X Funds 5.12% 228 NS 30 เมษายน 2026 N-PORT
SCHD · SCHWAB STRATEGIC TRUST 5.09% 12,713,822 NS 31 พฤษภาคม 2026 N-PORT
RXL · ProShares Trust 4.98% 9,446 NS 31 พฤษภาคม 2026 N-PORT
DOGG · First Trust Exchange-Traded Fund IV 4.95% 8,762 NS 30 เมษายน 2026 N-PORT
CURE · Direxion Shares ETF Trust 4.84% 18,062 NS 30 เมษายน 2026 N-PORT
DJIA · Global X Funds 4.63% 21,113 NS 30 เมษายน 2026 N-PORT
DYLG · Global X Funds 4.61% 732 NS 30 เมษายน 2026 N-PORT
VEGN · ETF Series Solutions 4.22% 17,678 NS 30 เมษายน 2026 N-PORT
IXJ · iShares Trust 4.16% 428,283 SH 8 สิงหาคม 2026 รายวัน
GFGF · EA Series Trust 3.98% 3,881 NS 29 พฤษภาคม 2026 N-PORT
EQIN · Columbia ETF Trust I 3.65% 27,252 NS 30 เมษายน 2026 N-PORT
LGRO · ALPS ETF Trust 3.45% 12,238 NS 31 พฤษภาคม 2026 N-PORT
JXX · Janus Detroit Street Trust 3.34% 3,270 NS 30 เมษายน 2026 N-PORT
PWV · Invesco Exchange-Traded Fund Trust 3.34% 146,788 SH 8 สิงหาคม 2026 รายวัน
DDM · ProShares Trust 3.30% 45,359 NS 31 พฤษภาคม 2026 N-PORT
PRVS · Parnassus Funds II 3.25% 1,978 NS 30 มิถุนายน 2026 N-PORT
BKDV · BNY Mellon ETF Trust II 3.14% 117,081 NS 30 เมษายน 2026 N-PORT
QLTY · GMO ETF Trust 2.85% 337,119 NS 31 พฤษภาคม 2026 N-PORT
AVIE · AMERICAN CENTURY ETF TRUST 2.72% 735 NS 31 พฤษภาคม 2026 N-PORT
FMCX · Northern Lights Fund Trust IV 2.67% 8,276 NS 31 พฤษภาคม 2026 N-PORT
FMCE · Northern Lights Fund Trust IV 2.67% 4,741 NS 31 พฤษภาคม 2026 N-PORT
CBLS · Elevation Series Trust 2.65% 3,800 NS 30 เมษายน 2026 N-PORT
UDOW · ProShares Trust 2.52% 55,671 NS 31 พฤษภาคม 2026 N-PORT
TBG · EA Series Trust 2.51% 15,609 NS 30 เมษายน 2026 N-PORT
ESN · Northern Lights Fund Trust II 2.47% 18,098 NS 31 พฤษภาคม 2026 N-PORT
OMAH · Tidal Trust III 2.46% 49,724 NS 30 เมษายน 2026 N-PORT
SNPV · DBX ETF Trust 2.35% 14,245 NS 29 พฤษภาคม 2026 N-PORT
PALC · Pacer Funds Trust 2.35% 14,601 NS 30 เมษายน 2026 N-PORT
FMED · Fidelity Covington Trust 2.25% 2,424 NS 31 พฤษภาคม 2026 N-PORT
RWL · Invesco Exchange-Traded Fund Trust … 2.20% 536,993 SH 8 สิงหาคม 2026 รายวัน
SFYF · Tidal Trust I 2.08% 2,389 NS 31 พฤษภาคม 2026 N-PORT
FLV · AMERICAN CENTURY ETF TRUST 2.07% 19,236 NS 31 พฤษภาคม 2026 N-PORT
HGRO · ETF Opportunities Trust 2.06% 5,413 NS 30 เมษายน 2026 N-PORT
CGDV · Capital Group Dividend Value ETF 2.02% 1,872,479 NS 31 พฤษภาคม 2026 N-PORT
GMOV · GMO ETF Trust 2.02% 4,839 NS 31 พฤษภาคม 2026 N-PORT
GKAT · Advisors Series Trust 1.99% 10,970 NS 31 มีนาคม 2026 N-PORT
DUSA · Davis Fundamental ETF Trust 1.96% 61,270 NS 30 เมษายน 2026 N-PORT
GVIP · Goldman Sachs ETF Trust 1.84% 27,590 NS 31 พฤษภาคม 2026 N-PORT
MGV · VANGUARD WORLD FUND 1.78% 570,801 SH 8 สิงหาคม 2026 รายวัน
MEDI · Harbor ETF Trust 1.77% 1,315 NS 30 เมษายน 2026 N-PORT
KAT · Advisors Series Trust 1.75% 43,653 NS 31 มีนาคม 2026 N-PORT
DGRO · iShares Trust 1.69% 1,819,359 SH 8 สิงหาคม 2026 รายวัน
VIG · VANGUARD SPECIALIZED FUNDS 1.65% 5,130,541 SH 8 สิงหาคม 2026 รายวัน